SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000819050-21-000013
Filing Date
2021-03-02
Accepted
2021-03-02 16:18:41
Documents
5
Period of Report
2021-03-02

Document Format Files

Seq Description Document Type Size
1 PRE 14A a20210301pre-14a.htm PRE 14A 1156402
2 card11.jpg GRAPHIC 154751
3 card21.jpg GRAPHIC 225967
4 card31.jpg GRAPHIC 59448
5 card41.jpg GRAPHIC 333574
  Complete submission text file 0000819050-21-000013.txt   2223097
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-21088 | Film No.: 21703857
SIC: 2836 Biological Products, (No Diagnostic Substances)